Logo image of LIFW

MSP RECOVERY INC (LIFW) Stock Fundamental Analysis

NASDAQ:LIFW - Nasdaq - US5537452097 - Common Stock - Currency: USD

3.24  +1.65 (+103.77%)

After market: 2.73 -0.51 (-15.74%)

Fundamental Rating

1

Overall LIFW gets a fundamental rating of 1 out of 10. We evaluated LIFW against 103 industry peers in the Health Care Providers & Services industry. LIFW has a bad profitability rating. Also its financial health evaluation is rather negative. LIFW is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LIFW had negative earnings in the past year.
LIFW had a negative operating cash flow in the past year.
LIFW Yearly Net Income VS EBIT VS OCF VS FCFLIFW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

LIFW has a Return On Assets (-3.49%) which is comparable to the rest of the industry.
LIFW's Return On Equity of -32.40% is on the low side compared to the rest of the industry. LIFW is outperformed by 66.06% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIFW Yearly ROA, ROE, ROICLIFW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

The Gross Margin of LIFW (66.22%) is better than 88.99% of its industry peers.
In the last couple of years the Gross Margin of LIFW has declined.
LIFW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
LIFW Yearly Profit, Operating, Gross MarginsLIFW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

LIFW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LIFW has less shares outstanding
LIFW has a worse debt/assets ratio than last year.
LIFW Yearly Shares OutstandingLIFW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1B 2B 3B
LIFW Yearly Total Debt VS Total AssetsLIFW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

LIFW has an Altman-Z score of -1.22. This is a bad value and indicates that LIFW is not financially healthy and even has some risk of bankruptcy.
LIFW's Altman-Z score of -1.22 is on the low side compared to the rest of the industry. LIFW is outperformed by 81.65% of its industry peers.
A Debt/Equity ratio of 2.54 is on the high side and indicates that LIFW has dependencies on debt financing.
LIFW has a worse Debt to Equity ratio (2.54) than 77.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC4.13%
LIFW Yearly LT Debt VS Equity VS FCFLIFW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

LIFW has a Current Ratio of 0.01. This is a bad value and indicates that LIFW is not financially healthy enough and could expect problems in meeting its short term obligations.
LIFW has a worse Current ratio (0.01) than 97.25% of its industry peers.
A Quick Ratio of 0.01 indicates that LIFW may have some problems paying its short term obligations.
The Quick ratio of LIFW (0.01) is worse than 97.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
LIFW Yearly Current Assets VS Current LiabilitesLIFW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for LIFW have decreased strongly by -1533.49% in the last year.
LIFW shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.67%.
Measured over the past years, LIFW shows a very negative growth in Revenue. The Revenue has been decreasing by -17.83% on average per year.
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LIFW Yearly Revenue VS EstimatesLIFW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2B 4B 6B
LIFW Yearly EPS VS EstimatesLIFW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 10 20 30 40 50

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LIFW. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 0.10 indicates a rather cheap valuation of LIFW.
LIFW's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIFW is cheaper than 100.00% of the companies in the same industry.
LIFW is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 0.1
LIFW Price Earnings VS Forward Price EarningsLIFW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFW Per share dataLIFW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

LIFW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LIFW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MSP RECOVERY INC

NASDAQ:LIFW (12/6/2024, 8:00:02 PM)

After market: 2.73 -0.51 (-15.74%)

3.24

+1.65 (+103.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners47.79%
Inst Owner Change3.03%
Ins Owners183.4%
Ins Owner Change0%
Market Cap21.25M
Analysts82.86
Price Target3.06 (-5.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.1
P/S 1.98
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-101.6
EYN/A
EPS(NY)31.2
Fwd EY963.02%
FCF(TTM)-4.41
FCFYN/A
OCF(TTM)-4.02
OCFYN/A
SpS1.64
BVpS45.78
TBVpS-376.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.22%
FCFM N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.53%
Cap/Sales 23.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.22
F-Score3
WACC4.13%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.37%
OCF growth 3YN/A
OCF growth 5YN/A